A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin's lymphoma

被引：0
|
作者：
Tulpule, A [1 ]
Khan, AU [1 ]
Mohrbacher, AF [1 ]
Espina, BM [1 ]
Buchanan, L [1 ]
Berman, N [1 ]
Gorospe, G [1 ]
Boswell, WD [1 ]
Nathwani, BN [1 ]
Levine, AM [1 ]
机构：
[1] USC, Keck Sch Med, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6688
引用
收藏
页码：604S / 604S
页数：1
相关论文
共 50 条
  • [41] Liposomal encapsulated doxorubicin (Caelyx) in the treatment of relapsed aggressive non-Hodgkin's lymphoma: A phase II study
    Macpherson, N.
    Belch, A.
    Taylor, M.
    Sutherland, J.
    Czaykowski, P.
    Connors, J.
    LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1327 - 1332
  • [42] Liposomal doxorubicin (TLC-D99) in combination with cyclophosphamide (C), vincristine (V), and prednisone (P) is active in newly diagnosed aggressive non-Hodgkin's lymphoma (NHL).
    Tulpule, A
    Espina, BM
    Berman, N
    Buchanan, LH
    Boswell, WD
    Welles, L
    Levine, AM
    BLOOD, 2001, 98 (11) : 346A - 346A
  • [43] PHASE 1B STUDY COMBINING IBRUTINIB WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISONE (R-CHOP) IN PATIENTS WITH CD20-POSITIVE B-CELL NON-HODGKIN LYMPHOMA (NHL)
    Younes, A.
    Flinn, I.
    Berdeja, J.
    Friedberg, J.
    Alberti, S.
    Thieblemont, C.
    Morschhauser, F.
    Hellemans, P.
    Hall, B.
    Smit, J.
    Skee, D.
    de Vries, R.
    Todorovic, M.
    Khan, I.
    Fourneau, N.
    Oki, Y.
    HAEMATOLOGICA, 2013, 98 : 356 - 356
  • [44] Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment of primary gastrointestinal B-cell lymphoma
    Aguiar Bujanda, D.
    Cabrera Suarez, M. A.
    Llorca Martinez, I.
    Bohn Sarmiento, U.
    Saura Grau, S.
    Rodriguez Franco, C.
    Aguiar Morales, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
    Vitolo, Umberto
    Trneny, Marek
    Belada, David
    Burke, John M.
    Carella, Angelo Michele
    Chua, Neil
    Abrisqueta, Pau
    Demeter, Judit
    Flinn, Ian
    Hong, Xiaonan
    Kim, Won Seog
    Pinto, Antonio
    Shi, Yuan-Kai
    Tatsumi, Yoichi
    Oestergaard, Mikkel Z.
    Wenger, Michael
    Fingerle-Rowson, Gunter
    Catalani, Olivier
    Nielsen, Tina
    Martelli, Maurizio
    Sehn, Laurie H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31) : 3529 - +
  • [46] Pegylated Liposomal Doxorubicin, Rituximab, Cyclophosphamide, Vincristine, and Prednisone in AIDS-Related Lymphoma: AIDS Malignancy Consortium Study 047
    Levine, Alexandra M.
    Noy, Ariela
    Lee, Jeannette Y.
    Tam, Wayne
    Ramos, Juan Carlos
    Henry, David H.
    Parekh, Samir
    Reid, Erin G.
    Mitsuyasu, Ronald
    Cooley, Timothy
    Dezube, Bruce J.
    Ratner, Lee
    Cesarman, Ethel
    Tulpule, Anil
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) : 58 - 64
  • [47] Granulocyte Colony-Stimulating Factor (GCSF) Use with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone plus /- Rituximab ( CHOP±R) Treatment for Aggressive Non-Hodgkin's Lymphoma (aNHL)
    Kouroukis, Tom
    Cheung, Winson Y.
    Abdel-Samad, Nizar
    Sehdev, Sandeep
    Poulin-Costello, Melanie
    Gillesby, Brad
    Robson, Ewan J. D.
    BLOOD, 2016, 128 (22)
  • [48] A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma
    Mitchell, Paul L. R.
    Marlton, Paula
    Grigg, Andrew
    Seymour, John F.
    Hertzberg, Mark
    Enno, Arno
    Herrmann, Richard
    Bond, Rodney
    Arthur, Chris
    LEUKEMIA & LYMPHOMA, 2008, 49 (05) : 924 - 931
  • [49] Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab
    Zhou, Ting
    Shen, Qian
    Peng, Hui
    Chao, Tengfei
    Zhang, Lihong
    Huang, Liu
    Yang, Kaixiang
    Thapa, Sudip
    Yu, Shiying
    Jiang, Yongsheng
    ANNALS OF HEMATOLOGY, 2018, 97 (01) : 141 - 147
  • [50] The POLARIX Study: Polatuzumab Vedotin With Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone vs Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (02) : 10 - 11
12345